NCT01893125View on ClinicalTrials.gov

Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

September 30, 2014

Conditions
Diabetic Peripheral Neuropathy
Interventions
DRUG

CNV2197944

DRUG

Placebo

Trial Locations (1)

H-9002

Petz Aladar County Teaching Hospital, Győr

Sponsors
All Listed Sponsors
lead

Convergence Pharmaceuticals

INDUSTRY